ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 135 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2021. The put-call ratio across all filers is 3.64 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $234,000 | -65.5% | 21,570 | -67.3% | 0.00% | -100.0% |
| Q3 2020 | $679,000 | -63.6% | 65,878 | -26.2% | 0.00% | -66.7% |
| Q2 2020 | $1,865,000 | +7.6% | 89,320 | -49.7% | 0.00% | 0.0% |
| Q1 2020 | $1,733,000 | +289.4% | 177,428 | +358.9% | 0.00% | +200.0% |
| Q4 2019 | $445,000 | +179.9% | 38,666 | +32.8% | 0.00% | – |
| Q3 2019 | $159,000 | -44.8% | 29,119 | +20.0% | 0.00% | – |
| Q2 2019 | $288,000 | +59.1% | 24,261 | -29.9% | 0.00% | – |
| Q1 2019 | $181,000 | -25.8% | 34,591 | -55.3% | 0.00% | – |
| Q4 2018 | $244,000 | -71.0% | 77,386 | -44.4% | 0.00% | -100.0% |
| Q3 2018 | $841,000 | +357.1% | 139,078 | +300.0% | 0.00% | – |
| Q2 2018 | $184,000 | -53.1% | 34,772 | -71.9% | 0.00% | -100.0% |
| Q2 2016 | $392,000 | – | 123,953 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |